Skip to content

Acupuncture in Patients With Stable Angina Pectoris

Effect of Acupuncture in Patients With Stable Angina Pectoris: an Open Label, Randomized, Controlled,Multi-center Clinical Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01686230
Acronym
ASAP
Enrollment
404
Registered
2012-09-17
Start date
2012-07-31
Completion date
2017-07-31
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina, Stable

Keywords

acupuncture, Angina, Stable Angina Pectoris

Brief summary

This trail aims to evaluate the efficacy of acupoints on the specific meridian for chronic stable angina pectoris, compared with acupoints on the other meridian, sham acupoints and waiting-list. And to confirm the specificity of acupoints on meridian.

Detailed description

The basis of acupuncture is the theory of meridians and acupoints. Meridian and collaterals internally pertain to viscera, and externally spread over the extremities. An acupoint is the place where the visceral qi and meridian qi distributed in. besides acupoints are the stimulus points and reactive points for acupuncture to treat the diseases. Selecting the acupoints on the specific meridian is the basic principle of acupuncture. Recently, as to the existence of specificity of acupoints on the meridian has been questioned by many researchers. This trial using chronic stable angina pectoris as a carrier, select the acupoints on the hand shao yin heart meridian and hand jue yin pericardium meridian to treat chronic stable angina pectoris. Compared with acupoints on the other meridian and non-acupoints ,aiming to evaluate the efficacy, furthermore ,to confirm the existence of the specificity of acupoints on meridian.

Interventions

OTHERacupuncture

In each session, we treat bilaterally, 3 times a week and 2 days off a week, each patient in the acupuncture treatment groups will receive 12 sessions of acupuncture treatment over 4 weeks. The whole study period is 20 weeks including 4-week baseline period,4-week treatment period, and 12-week follow-up period. we will investigate at 0 day,4week,8week,12week,16week after randomization。

DRUGBasic treatment

Each group in the basic treatment,Foundation treatment including health education and basic drug therapy. We recommend lifestyle modification for all patients. Modifications include increasing exercise; limiting alcohol consumption; and weight loss; quit smorking etc. Basic medication: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.

Sponsors

Hunan University of Traditional Chinese Medicine
CollaboratorOTHER
Chengdu University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1.Meet the diagnostic criteria of ACC/AHA angina pectoris of coronary heart disease. 2.35 ≤ age ≤ 80 years of age, both male and female. 3.The onset of angina pectoris≥3 months, and the frequency of angina attack≥2 a week. 4.Patients signed the informed consent.

Exclusion criteria

1. age≤35 or age≥80 2. Pregnant women or women in lactation or women of child bearing potential plan to conceive in the recent six months. 3. Combined with cardiovascular, digestive, respiratory, urinary, blood, nervous, endocrine system, severe primary disease clinical failed to effectively control the disease. 4. Complicated with mental disorders. 5. allergic constitution or bleeding disorder. 6. Patients accompany with acute coronary syndrome (including acute myocardial infarction, unstable angina), severe arrhythmias ( severe atrioventricular block, ventricular tachycardia, heartbeat influence the flow dynamics in supraventricular tachycardia, heartbeat frequent premature beats especially premature ventricular contractions ), atrial fibrillation, primary cardiomyopathy, valvular heart disease. 7. The blood pressure and blood glucose fail to meet the treatment targets. 8. Cardiovascular disease who had been treated with acupuncture during the previous three months. 9. Currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frameDescription
Number of angina attacks16 weeks after inclusionThe frequency of angina attack during 4-week.

Secondary

MeasureTime frameDescription
The dosage of nitroglycerin0 day,4, 8, 12, 16 weeks after inclusion
Six minute walk test0 day and 4 weeks after inclusionSix minute walk test in the evaluation of exercise tolerance
Dynamic ECG Observation of the changes of ST-T0 day and 4 weeks after inclusionDynamic electrocardiogram in six minute walk test to do
The severity of angina ( VAS score)0 day,4, 8, 12, 16 weeks after inclusionThe VAS score evaluation angina pain severity
self-rating anxiety scale0 day,4, 8, 16 weeks after inclusion
The incidence of cardiovascular episode during the 4 months4, 8, 12, 16 weeks after inclusionThe incidence of cardiovascular episode during the 4 months(develop into unstable angina, acute myocardial infarction, death)
Self-rating Depression Scale0 day,4, 8, 16 weeks after inclusion
The Seattle Angina Questionnaire ( SAQ ) score0 day,4, 8, 12, 16 weeks after inclusion

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026